Login / Signup

Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)?

Laura HarrisonDermot Gleeson
Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)
While further studies are needed, evidence supports a strategy of IST withdrawal in some patients with AIH who have achieved remission.
Keyphrases
  • multiple sclerosis
  • disease activity
  • rheumatoid arthritis
  • combination therapy
  • ulcerative colitis
  • replacement therapy